How AI Is Changing Drug Discovery at Isomorphic Labs
Bloomberg Live · 19:00 · Watch on YouTube
Isomorphic Labs, the 2021 DeepMind spin-out, is building an AI drug-design engine to make medicines rather than sell model access, pairing self-funded programs in oncology and immunology with pharma partnerships, and...